long-term follow-up of the tourmaline-mm1 trial
Published 2 years ago • 28 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
4:48
overview of the final analysis of the phase iii tourmaline-mm1 trial
-
1:22
long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
-
4:24
long-term follow-up of a "fast-dc" immunotherapy as a post-remission strategy for aml
-
1:33
tourmaline-mm3: undetectable mrd as an endpoint for maintenance therapy
-
10:36
x-therma preservation platform
-
1:00:56
lmp grand rounds sthomas 18jan2023
-
10:07
j.a. woolam m-2000 training video
-
1:36
tourmaline-al1: ixazomib-dexamethasone for al amyloidosis
-
8:26
triple combination therapies for multiple myeloma (mm) patients
-
1:04
results of the aspire trial for mm: the addition of carfilzomib
-
5:30
determination: rvd vs high-dose melphalan conditioning with autohsct in ndmm
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
5:54
redirectt-1 results: teclistamab talquetamab in r/r multiple myeloma
-
1:30
outcomes in rrmm treated with ird in the real world
-
3:28
molecular prognostication in smm
-
0:51
challenges in managing myeloma patients
-
1:37
mrd in myeloma
-
3:42
measuring whole blood thrombin generation in patients with multiple myeloma
-
2:01
real-world results of an in-class transition from vrd to ird in myeloma
-
3:16
what to look forward to at imw 2021
-
4:23
ifm 2018-02: ixazomib daratumumab in elderly frail patients with r/r multiple myeloma